Detalhe da pesquisa
1.
Trastuzumab Deruxtecan in HER2-Mutant Non-Small-Cell Lung Cancer.
N Engl J Med
; 386(3): 241-251, 2022 01 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34534430
2.
Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer.
N Engl J Med
; 382(7): 610-621, 2020 02 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31825192
3.
Trastuzumab deruxtecan (DS-8201) in patients with HER2-expressing metastatic colorectal cancer (DESTINY-CRC01): a multicentre, open-label, phase 2 trial.
Lancet Oncol
; 22(6): 779-789, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33961795
4.
Trastuzumab deruxtecan (DS-8201a) in patients with advanced HER2-positive gastric cancer: a dose-expansion, phase 1 study.
Lancet Oncol
; 20(6): 827-836, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31047804
5.
Trastuzumab deruxtecan (DS-8201a) in patients with advanced HER2-positive breast cancer previously treated with trastuzumab emtansine: a dose-expansion, phase 1 study.
Lancet Oncol
; 20(6): 816-826, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31047803
6.
More comprehensively measuring quality of life in life-threatening illness: the McGill Quality of Life Questionnaire - Expanded.
BMC Palliat Care
; 18(1): 92, 2019 Oct 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-31672131
7.
Measuring the quality of life of people at the end of life: The McGill Quality of Life Questionnaire-Revised.
Palliat Med
; 31(2): 120-129, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27412257
8.
Exposure-Response Relationships in Patients With HER2-Positive Metastatic Breast Cancer and Other Solid Tumors Treated With Trastuzumab Deruxtecan.
Clin Pharmacol Ther
; 110(4): 986-996, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33999422
9.
Quality of life in terminally ill cancer patients: contributors and content validity of instruments.
J Palliat Care
; 26(2): 88-93, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20718393
10.
Antitumor Activity and Safety of Trastuzumab Deruxtecan in Patients With HER2-Low-Expressing Advanced Breast Cancer: Results From a Phase Ib Study.
J Clin Oncol
; 38(17): 1887-1896, 2020 06 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32058843
11.
McGill Quality of Life Questionnaire: reliability and validity of the Persian version in Iranian patients with advanced cancer.
J Palliat Med
; 11(4): 621-6, 2008 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-18454615
12.
Treatment and prognosis of epithelial ovarian cancer: five year multi-center study.
Saudi Med J
; 29(12): 1735-8, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19082223
13.
EGFR Gene Copy Number by FISH May Predict Outcome of Necitumumab in Squamous Lung Carcinomas: Analysis from the SQUIRE Study.
J Thorac Oncol
; 13(2): 228-236, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29158193
14.
Venous thromboembolism with EGFR monoclonal antibody necitumumab in stage IV non-small cell lung cancer: A retrospective cohort analysis.
Thromb Res
; 167: 50-56, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29787943
15.
Reimagining patient-centric cancer clinical trials: a multi-stakeholder international coalition.
Nat Med
; 28(4): 620-626, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35440725
16.
Reply to T.J.A. Dekker.
J Clin Oncol
; 38(28): 3351-3352, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32658630
17.
Changes in daily activities of cancer patients after diagnosis: how do canadian and Iranian patients perceive the change?
Iran J Cancer Prev
; 7(1): 28-34, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25250145
18.
The impact of multiple recurrences in disease-free survival of breast cancer: an extended Cox model.
Tumori
; 98(4): 428-33, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23052157